From 1 July 2023, ODT medicines will become part of the Section 100 Highly Specialised Drugs (HSD) Program (Community Access) arrangements. This means ODT medicines will be dispensed in the same way as other community access Section 100 HSD Program medicines from section 90 approved community pharmacies, section 92 approved medical practitioners, and section 94 approved hospital authorities (public and private).
More than eight million dollars will be provided to 339 general practices across the Hunter, New England and Central Coast regions, under the Commonwealth Government’s Strengthening Medicare Grants Program, being facilitated by the PHN.
The Cancer Institute NSW and Calvary Mater Newcastle are seeking expressions of interest for membership to their prostate cancer and colon cancer implementation working groups.
The RACGP has compiled links to information about the Medicare Benefits Schedule (MBS) and Medicare compliance so GPs and practice teams can easily access these from one central location.
Is your practice prepared if a patient discloses DFSV or abuse? A conversation could save a life.
Read all of the April updates to the HNE HealthPathways
The (CSIRO) ‘Risk of Hospitalisation’ Report is an all-new Clinical Audit Tool (CAT) capability, which may determine the probability that a patient will make an unplanned hospital visit within 12- months.
Head and Neck Cancer Australia has created the first accredited GP and Dentist Online Education Module, aimed at early detection and optimal referral pathways. There are no screening tests for Head and Neck Cancer (HNC), so the earlier these cancers are diagnosed, and patients are referred to a specialist for further management, the better their outcomes.
Grants of up to $50,000 will be available to general practices to make improvements to their operations, to expand patient access and provide better, safe, accessible quality care.
Osteoporosis Australia (OA) now known as Healthy Bones Australia hosted a National Forum with leading Australian clinical experts to develop a Position Statement on the management of osteoporosis.